Medicamen Biotech Limited — Nystatin Exporter Profile
Indian Pharmaceutical Exporter · #14 for Nystatin · $694.6K export value · DGFT Verified
Medicamen Biotech Limited is the #14 Indian exporter of Nystatin with $694.6K in export value and 41 verified shipments. Medicamen Biotech Limited holds a 1.3% market share in Nystatin exports across 10 countries. The company exports 8 pharmaceutical products worth $5.3M across 6 therapeutic categories.
Medicamen Biotech Limited — Nystatin Export Profile: Buyers & Destinations
Where Does Medicamen Biotech Limited Export Nystatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CAMEROON | $217.0K | 12 | 47.9% |
| BURKINA FASO | $100.0K | 4 | 22.1% |
| GHANA | $68.5K | 2 | 15.1% |
| TOGO | $50.0K | 2 | 11.0% |
| KENYA | $16.4K | 1 | 3.6% |
| BENIN | $1.1K | 10 | 0.3% |
| SENEGAL | $124 | 4 | 0.0% |
| MALI | $70 | 3 | 0.0% |
| NIGERIA | $15 | 1 | 0.0% |
| NIGER | $0 | 2 | 0.0% |
Medicamen Biotech Limited exports Nystatin to 10 countries. The largest destination is CAMEROON accounting for 47.9% of Medicamen Biotech Limited's Nystatin shipments, followed by BURKINA FASO (22.1%) and GHANA (15.1%). These destinations reflect Medicamen Biotech Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Nystatin from Medicamen Biotech Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SAPP SOCIETE AFRICAINE DES | CAMEROON | $150.0K | 3 |
| GOKALS LABOREX | GHANA | $68.5K | 2 |
| PHARMEZON SARL | CAMEROON | $67.0K | 3 |
| TO THE ORDER OF | KENYA | $66.4K | 2 |
| CAMEG TOGO | TOGO | $50.0K | 1 |
| BANQUE COMMERCIAL E DU BURKINA | BURKINA FASO | $50.0K | 1 |
| GOS T MECO PHARMA | BENIN | $1.1K | 10 |
| SHANIDAR PHARMA | SENEGAL | $124 | 4 |
| M/S OMT INTERNATIONAL | MALI | $70 | 3 |
| SOCIETE AFRICAINE DES PRODUITS | CAMEROON | $27 | 6 |
Medicamen Biotech Limited supplies Nystatin to 14 buyers globally. The largest buyer is SAPP SOCIETE AFRICAINE DES (CAMEROON), followed by GOKALS LABOREX (GHANA) and PHARMEZON SARL (CAMEROON). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Nystatin Export Value and How Much Does Medicamen Biotech Limited Contribute?
India exported $26.6M worth of Nystatin through 2,442 shipments from 223 suppliers to 96 countries, serving 458 buyers globally. Medicamen Biotech Limited contributes $694.6K to this total, accounting for 1.3% of India's Nystatin exports. Medicamen Biotech Limited ships Nystatin to 10 countries through 14 buyers.
What Is the Average Shipment Value for Medicamen Biotech Limited's Nystatin Exports?
Medicamen Biotech Limited's average Nystatin shipment value is $16.9K per consignment, based on 41 shipments totaling $694.6K. The largest destination is CAMEROON (47.9% of Medicamen Biotech Limited's Nystatin exports).
How Does Medicamen Biotech Limited Compare to Other Indian Nystatin Exporters?
Medicamen Biotech Limited ranks #14 among 223 Indian Nystatin exporters with a 1.3% market share. The top 3 exporters are ZYDUS LIFESCIENCES LIMITED ($6.4M), TORRENT PHARMACEUTICALS LTD ($4.2M), MEDLEY PHARMACEUTICALS LIMITED ($3.5M). Medicamen Biotech Limited processed 41 shipments to 10 destination countries.
What Nystatin Formulations Does Medicamen Biotech Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| NYSTATIN TABLET BP 500000 IU (10x10)Each film coated tablet contains: Nystatin BP 500000 IU (NET WEIGHT 604.838 KGS)NOS | $150.0K | 3 |
| NYSTATIN TABLETS BP 500000IU (10X10) [EA | $50.0K | 1 |
| Nystatin Oral Suspension BP 100000 IU [Each ml contains :Nystatin BP 100000 IU]200.320 KGS | $50.0K | 1 |
| Nystatin Oral Suspension BP 100000 IU Each ml contains Nystatin BP 100000 IU 30ML | $50.0K | 1 |
| Nymedi Nystatin Tablets BP 500000 IU 10000x1x10[Each tablet cont Nystatin BP 500000 IU]NT.WT.8.06 KGS | $34.3K | 1 |
| Nymedi-V Nystatin Vaginal Tablets BP 100000 IU 20000x1X14[Each tablet contains :Nystatin BP 100000 IU]nt.wt.4.516 k | $34.3K | 1 |
| NYSTATIN TABLETS BP 500000 IU EACH FILM | $28.2K | 1 |
| NYSTATIN VAGINAL TABLETS BP 100000 IU EA | $21.8K | 1 |
| NYSTATIN ORAL SUSPENSION BP 100000 IU EA | $17.0K | 1 |
| NYSTATIN VAGINAL TABLETS BP 100000 IU Each vaginal tablet contains Nystatin BP 1,00,000 IU NT.WT.16.935 KGS [75000X1X14] | $16.4K | 1 |
Medicamen Biotech Limited exports 33 distinct Nystatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is NYSTATIN TABLET BP 500000 IU (10x10)Each film coated tablet with 3 shipments worth $150.0K.
How Does Medicamen Biotech Limited Compare to Nearest Nystatin Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | TORRENT PHARMACEUTICALS LIMITED | $805.1K | 36 | 1 | $22.4K |
| 13 | CIPLA LIMITED | $721.6K | 46 | 4 | $15.7K |
| 14 | MEDICAMEN BIOTECH LIMITED ★ | $694.6K | 41 | 10 | $16.9K |
| 15 | VANSH REMEDIES | $250.0K | 5 | 3 | $50.0K |
Medicamen Biotech Limited ranks #14 among 223 Indian Nystatin exporters. Average shipment value of $16.9K compared to the market average of $119.3K. The closest competitors by value are TORRENT PHARMACEUTICALS LIMITED and CIPLA LIMITED.
Which Indian Ports Ship Nystatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 485 | 19.9% |
| JNPT/ NHAVA SHEVA SEA | 277 | 11.3% |
| JNPT | 208 | 8.5% |
| MUNDRA SEA | 120 | 4.9% |
| DELHI AIR | 105 | 4.3% |
| MUNDRA SEA (INMUN1) | 97 | 4.0% |
| AHEMDABAD ICD | 91 | 3.7% |
| DELHI AIR CARGO ACC (INDEL4) | 81 | 3.3% |
About Medicamen Biotech Limited
Medicamen Biotech Limited exports 8 products worth $5.3M. Beyond Nystatin, top products include Folic, Trimethoprim, Diphenhydramine, Sulfamethoxazole, Norfloxacin. View the complete Medicamen Biotech Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Nystatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Nystatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medicamen Biotech Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 41 individual customs records matching Medicamen Biotech Limited exporting Nystatin, covering 33 formulations to 10 countries via 14 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 96+ countries, 458+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Nystatin Export Data from Medicamen Biotech Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medicamen Biotech Limited's Nystatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medicamen Biotech Limited
Full Company Profile →
8 products · $5.3M total trade · 6 categories
Nystatin Stats
Company Overview
Top Products by Medicamen Biotech Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medicamen Biotech Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Nystatin. For current shipment-level data, contact TransData Nexus.